BALFX
Price
$37.57
Change
-$0.14 (-0.37%)
Updated
Aug 29 closing price
Net Assets
255.46B
IBNAX
Price
$25.31
Change
-$0.13 (-0.51%)
Updated
Aug 29 closing price
Net Assets
2.03B
Interact to see
Advertisement

BALFX vs IBNAX

Header iconBALFX vs IBNAX Comparison
Open Charts BALFX vs IBNAXBanner chart's image
American Funds American Balanced F1
Price$37.57
Change-$0.14 (-0.37%)
VolumeN/A
Net Assets255.46B
Macquarie Balanced Fund
Price$25.31
Change-$0.13 (-0.51%)
VolumeN/A
Net Assets2.03B
BALFX vs IBNAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALFX vs. IBNAX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Buy and IBNAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 255B vs. IBNAX (2.03B). BALFX pays higher dividends than IBNAX: BALFX (1.79) vs IBNAX (1.02). BALFX was incepted earlier than IBNAX: BALFX (24 years) vs IBNAX (38 years). IBNAX (1.08) is less costly to investors than BALFX (0.61). IBNAX is a more actively managed with annual turnover of: 76.00 vs. BALFX (44.00). BALFX has a lower initial minimum investment than IBNAX: BALFX (250) vs IBNAX (1000). IBNAX annual gain was more profitable for investors over the last year : 11.03 vs. BALFX (7.68). BALFX return over 5 years is better than : 36.77 vs. IBNAX (5.36).
BALFXIBNAXBALFX / IBNAX
Total Expense Ratio0.611.0658%
Annual Report Gross Expense Ratio0.611.0856%
Fund Existence24 years38 years-
Gain YTD10.1878.807116%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets255B2.03B12,574%
Annual Yield % from dividends1.791.02177%
Returns for 1 year7.6811.0370%
Returns for 3 years36.1114.14255%
Returns for 5 years36.775.36686%
Returns for 10 years76.2516.59460%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCYC7.380.30
+4.24%
Bicycle Therapeutics plc
MEDP475.512.57
+0.54%
Medpace Holdings
ENTX1.93-0.01
-0.52%
Entera Bio Ltd
DNLI15.27-0.38
-2.43%
Denali Therapeutics
SPHL0.43-0.05
-9.49%
Springview Holdings Ltd